NCT04388566

Brief Summary

Development of a Danish Sarcoidosis Registry. Characterization of a cohort of sarcoidosis patients with respect to the baseline epidemiological characteristics, comorbidities, radiology, histopathology, diagnostic investigations and treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 14, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2022

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

June 6, 2022

Status Verified

September 1, 2021

Enrollment Period

2.2 years

First QC Date

May 11, 2020

Last Update Submit

June 3, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Characterization of Danish sarcoid patients

    Epidemiology and Baseline characteristics of a Danish Sarcoidosis Cohort

    2 years

  • Feasibility and completion of a Sarcoidosis Registry.

    Development of a Danish sarcoidosis registry Data on epidemiology, clinical characteristics, diagnosis and management will be registered

    2 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with sarcoidosis seen in the Department of Respiratory Diseases, Aarhus Denmark

You may qualify if:

  • Diagnosis of sarcoidosis
  • Signed informed consent

You may not qualify if:

  • Inability or unwillingness to adhere to the study
  • Inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus N, 8200, Denmark

Location

MeSH Terms

Conditions

Sarcoidosis

Condition Hierarchy (Ancestors)

Lymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesHypersensitivity, DelayedHypersensitivityImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2020

First Posted

May 14, 2020

Study Start

December 1, 2019

Primary Completion

January 30, 2022

Study Completion

February 28, 2022

Last Updated

June 6, 2022

Record last verified: 2021-09

Locations